Page last updated: 2024-08-24

plerixafor and Minimal Disease, Residual

plerixafor has been researched along with Minimal Disease, Residual in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujita, K; Hatano, K; Kaneda, Y; Murakami, K; Nagahara, A; Nakai, Y; Nakayama, M; Nimura, K; Nonomura, N; Tsuchiya, M; Uemura, M; Yamaguchi, S	1
DiPersio, JF; Fruehauf, S; Hanrahan, J; Ho, AD; Hsu, FJ	1

Reviews

1 review(s) available for plerixafor and Minimal Disease, Residual

Article	Year
Relevance and clinical implications of tumor cell mobilization in the autologous transplant setting. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Biomarkers, Tumor; Combined Modality Therapy; Cyclams; Cytokines; DNA, Neoplasm; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Neoplasm, Residual; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Recurrence; Risk; Translocation, Genetic; Transplantation, Autologous; Treatment Outcome	2011

Article

Year

Relevance and clinical implications of tumor cell mobilization in the autologous transplant setting.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:7

Topics: Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Biomarkers, Tumor; Combined Modality Therapy; Cyclams; Cytokines; DNA, Neoplasm; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Neoplasm, Residual; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Recurrence; Risk; Translocation, Genetic; Transplantation, Autologous; Treatment Outcome

2011

Other Studies

1 other study(ies) available for plerixafor and Minimal Disease, Residual

Article	Year
Residual prostate cancer cells after docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4, ERK1/2 and c-Myc. Molecular cancer research : MCR, 2013, Volume: 11, Issue:9 Topics: Animals; Antineoplastic Agents; Benzylamines; Carcinogenesis; Cell Line, Tumor; Cyclams; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Male; MAP Kinase Signaling System; Mice, Nude; Mice, SCID; Neoplasm, Residual; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Receptors, CXCR4; Signal Transduction; Taxoids	2013

Article

Year

Residual prostate cancer cells after docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4, ERK1/2 and c-Myc.

Molecular cancer research : MCR, 2013, Volume: 11, Issue:9

Topics: Animals; Antineoplastic Agents; Benzylamines; Carcinogenesis; Cell Line, Tumor; Cyclams; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Male; MAP Kinase Signaling System; Mice, Nude; Mice, SCID; Neoplasm, Residual; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Receptors, CXCR4; Signal Transduction; Taxoids

2013